AnGes

4563 · TSE

Public Market Listing

4563TSE

TSE primary exchange listing

Live quotes, historical charts, and market capitalization for AnGes are available on Yahoo Finance.

View quote & market cap on Yahoo Finance ↗

External market data link · No third-party exchange redistribution

Assets

(1 total)
1Total Assets
0Approved
1Phase 3 / Filed
0Phase 1–2 / Early
1Diseases
Showing 1 of 1 assets
Target & Modality
Beperminogene perplasmid (HGF plasmid)(Collategene)No recent activity
Phase 3
HGF (hepatocyte growth factor) · Hepatocyte growth factor (HGF)Gene therapy / editing
Atherosclerotic Cardiovascular Disease

Upcoming events

No upcoming trial completions or earnings dates on record for this company's assets.

Financial reports

Annual history (2 years)

PeriodRevenueR&DCash & equiv.Net loss / qtrFiling
2025-FY$5.8M$24M$12M$34Mreport ↗
View 1 more year
PeriodRevenueR&DCash & equiv.Net loss / qtrFiling
2024-FY——$11M—report ↗